United Kingdom (GB)

close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Open-source codes for particle-shape characterisation, simplification and generation in numerical models: From imaging data to polyhedra and multi-sphere particles (2021) Angelidakis V, Nadimi S, Otsubo M, Utili S Conference contribution, Abstract of lecture Imaging the root–rhizosphere interface using micro computed tomography: quantifying void ratio and root volume ratio profiles (2021) Lascurain T, Angelidakis V, Luli S, Nadimi S Conference contribution, Original article DEM modelling of granular materials with real shape morphology (2021) Li Y, Otsubo M, Kuwano R, Nadimi S, Angelidakis V Journal article, Original article Kinematically exact peridynamics (2021) Javili A, McBride A, Steinmann P Authored book Monocular Reconstruction of Neural Face Reflectance Fields (2021) Mallikarjun BR, Tewari A, Oh TH, Weyrich T, Bickel B, Seidel HP, Pfister H, et al. Conference contribution Corrigendum to: More Than Smell-COVID-19 Is Associated With Severe Impairment of Smell, Taste, and Chemesthesis. (2021) Parma V, Ohla K, Veldhuizen MG, Niv MY, Kelly CE, Bakke AJ, Cooper KW, et al. Journal article, Erratum Optimisation of Region of Attraction Estimates for the Exponential Stabilisation of the Intrinsic Geometrically Exact Beam Model (2021) Artola M, Rodriguez C, Wynn A, Palacios R, Leugering G Conference contribution Recommendations for tilt table testing and other provocative cardiovascular autonomic tests in conditions that may cause transient loss of consciousness : Consensus statement of the European Federation of Autonomic Societies (EFAS) endorsed by the American Autonomic Society (AAS) and the European Academy of Neurology (EAN). (2021) Thijs RD, Brignole M, Falup-Pecurariu C, Fanciulli A, Freeman R, Guaraldi P, Jordan J, et al. Journal article Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): health-related quality-of-life results from a double-blind, randomised, controlled, phase 3 trial. (2021) Bottomley A, Coens C, Mierzynska J, Blank CU, Mandalà M, Long GV, Atkinson VG, et al. Journal article Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): distant metastasis-free survival results from a double-blind, randomised, controlled, phase 3 trial. (2021) Eggermont AM, Blank CU, Mandalà M, Long GV, Atkinson VG, Dalle S, Haydon AM, et al. Journal article